SCHEMBL13012736

SCHEMBL13012736

CN(C)CC1=CC(c2ccccc2)c2c(Cl)nc(=O)n(-c3ccccc3)c2N1

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 13/20 0.36
PRMT5 O14744 2/20 0.34
CYP1A2 P05177 1/20 0.34
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13012888 0.82 MAT2A (0.38) MAT2APRMT5LMNA
SCHEMBL13012735 0.80 HPGD (0.37) MAT2A
SCHEMBL13012886 0.78 MAT2A (0.35) MAT2APRMT5CYP1A2LMNA
SCHEMBL13012732 0.77 MAT2A (0.34) MAT2APRMT5CYP1A2
SCHEMBL3434846 0.68 MAT2A (0.33) MAT2ALMNA
SCHEMBL2726665 0.67 ADORA3 (0.51)
SCHEMBL3433377 0.60 MAT2A (0.39) MAT2A
SCHEMBL13012896 0.60 BRD4 (0.39) MAT2ALMNA
SCHEMBL22103638 0.59 MAT2A (0.76) MAT2APRMT5CYP1A2
SCHEMBL13012731 0.58 BRD4 (0.38) MAT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010149786-A1 PYRIDO [2, 3-D] PYRIMIDINES AS WNT ANTAGONISTS FOR TREATMENT OF CANCER AND ARTHRITIS DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2010-12-29 WO disclosed
EP-2266984-A1 Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2010-12-29 EP disclosed